Thanks for the suggestion however cancer is a very complex disease. There are hundreds of types/subtypes and the patient’s cancer needs to be an optimal match for the treatment used for any chance of success.
After failing two forms of immunotherapy I have had a sample of my cancer screened against 42 drugs in the US. It responded to 26 of them so I have lots of chemo options identified from this with a varying probability of working. Two of the drug responses were exceptional so one of these is the first chemo option I will try.
Due to an immunotherapy treatment I failed on trial and also surgery there are fewer and fewer trials I would be eligible for anyway. My tumour response on that trial was mixed CR/PR for some tumours, however my cancer eventually progressed.
General comments/chat, page-37883
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $27.42M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $3.825K | 537.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 23701100 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 6161168 | 11 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| ADN (ASX) Chart |